Engineering the assemblies of biomaterial nanocarriers for delivery of multiple theranostic agents with enhanced antitumor efficacy.
about
A Review of Paclitaxel and Novel Formulations Including Those Suitable for Use in DogsAn open-label, multicenter, phase I trial of a cremophor-free, polymeric micelle formulation of paclitaxel combined with carboplatin as a first-line treatment for advanced ovarian cancer: a Korean Gynecologic Oncology Group study (KGOG-3016).Inhibition of platelet function using liposomal nanoparticles blocks tumor metastasis.Stimuli-Responsive Mesoporous Silica NPs as Non-viral Dual siRNA/Chemotherapy Carriers for Triple Negative Breast Cancer.Luminescent/magnetic PLGA-based hybrid nanocomposites: a smart nanocarrier system for targeted codelivery and dual-modality imaging in cancer theranostics.Co-delivery of microRNA-21 antisense oligonucleotides and gemcitabine using nanomedicine for pancreatic cancer therapy.Nanoparticles with Precise Ratiometric Co-Loading and Co-Delivery of Gemcitabine Monophosphate and Cisplatin for Treatment of Bladder Cancer.Multifunctional theranostic nanoplatform for cancer combined therapy based on gold nanorods.A Near-Infrared Laser-Activated "Nanobomb" for Breaking the Barriers to MicroRNA Delivery.Biocompatible oil core nanocapsules as potential co-carriers of paclitaxel and fluorescent markers: preparation, characterization, and bioimaging.Osteoclast-derived microRNA-containing exosomes selectively inhibit osteoblast activitySupramolecular PEGylated Dendritic Systems as pH/Redox Dual-Responsive Theranostic Nanoplatforms for Platinum Drug Delivery and NIR Imaging.Applications of nanomaterials as vaccine adjuvants.Multifunctional enveloped mesoporous silica nanoparticles for subcellular co-delivery of drug and therapeutic peptide.Nanotechnological strategies for therapeutic targeting of tumor vasculature.Co-delivery of docetaxel and silibinin using pH-sensitive micelles improves therapy of metastatic breast cancer.Multi-layered polymeric nanoparticles for pH-responsive and sequenced release of theranostic agents.Peptide assembly integration of fibroblast-targeting and cell-penetration features for enhanced antitumor drug delivery.Synergistic antitumor effects of doxorubicin-loaded carboxymethyl cellulose nanoparticle in combination with endostar for effective treatment of non-small-cell lung cancer.A FRET-based dual-targeting theranostic chimeric peptide for tumor therapy and real-time apoptosis imaging.Biomaterials for Abrogating Metastasis: Bridging the Gap between Basic and Translational Research.Multiple Layer-by-Layer Lipid-Polymer Hybrid Nanoparticles for Improved FOLFIRINOX Chemotherapy in Pancreatic Tumor ModelsEfficient and tumor-specific knockdown of MTDH gene attenuates paclitaxel resistance of breast cancer cells both in vivo and in vitro
P2860
Q26801149-F0A37E6A-9D5A-47A6-AECC-E22E078A8431Q33563915-4C0EF0BB-A57C-4C3D-819A-0DD585C04D48Q33588139-F623F55F-15C3-4AD2-968F-AAC448CC814AQ33635355-E9D665DD-DEA8-4716-8CDA-BDC5E122B722Q33807175-ADFC45DF-9F57-48A0-85E9-A1E44D787F11Q33873637-EF586C16-E9E2-4395-96AD-3094AE10EF23Q34479313-AAD84A04-281E-463F-BD9D-103BC6C9E032Q35762630-C351DD9D-07CF-4D4E-82E6-20FB2911AA35Q35841342-C1AEB83A-8F7B-4774-B06E-5F097CB1AC17Q35894223-7E40CBF9-DB1A-4026-A7C1-4022309A7911Q36950997-6D0212D4-D11D-4612-A28B-F665EA6F5206Q37045940-F293DABD-9374-4496-AAF3-4665C8EA25DBQ37159697-364E6E10-6377-48EC-87AF-BCAC7E03CE2EQ37735009-395AA2FC-16E5-4624-AD1A-BB55E202CB51Q38120320-0CFF6A83-2E10-4C40-B661-6E2534599F29Q38697217-42AC409D-F5D8-4750-B1B8-3F2C5685B1ECQ38889924-CAAC286F-3080-416C-B92F-189CA3FF5CE6Q38912989-EA77BEF7-3D6C-4591-815D-DEF96FAA625BQ38993179-C8101AC1-341A-4F05-A75B-ABF4FC8C563EQ39007998-D9BD76CB-E2F5-449F-A143-48F0001AD21CQ51231785-1085C61F-B825-4466-A0E0-A0F63D899BD6Q58235064-066DF9C3-6433-46DD-8002-760D49992231Q58725311-EC39EE26-BAEB-4D86-B154-0E4B2989AD7A
P2860
Engineering the assemblies of biomaterial nanocarriers for delivery of multiple theranostic agents with enhanced antitumor efficacy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Engineering the assemblies of ...... h enhanced antitumor efficacy.
@en
Engineering the assemblies of ...... h enhanced antitumor efficacy.
@nl
type
label
Engineering the assemblies of ...... h enhanced antitumor efficacy.
@en
Engineering the assemblies of ...... h enhanced antitumor efficacy.
@nl
prefLabel
Engineering the assemblies of ...... h enhanced antitumor efficacy.
@en
Engineering the assemblies of ...... h enhanced antitumor efficacy.
@nl
P2093
P2860
P356
P1433
P1476
Engineering the assemblies of ...... h enhanced antitumor efficacy.
@en
P2093
P2860
P304
P356
10.1002/ADMA.201204750
P407
P50
P577
2013-01-22T00:00:00Z